EDUCATION, TRAINING, BOARD CERTIFICATIONS
- M.D., University Autonoma of Barcelona
- Residency, Hospital de Sant Pau Universitat Autònoma de Barcelona, Medical Oncology.
- Fellowship, Hospital de Sant Pau Universitat Autònoma de Barcelona, Oncology. Johns Hopkins University School of Medicine, Oncology.
National Institutes of Health, Hematology and Oncology
- Internal Medicine, American Board of Internal Medicine
- Medical Oncology, American Board of Internal Medicine
CLINICAL EXPERTISE
- Genitourinary tumors
- Urologic cancers
AFFILIATIONS
PUBLICATIONS
Research and/or Clinical Intrerests
Dr. Nadal's research involves studying novel targeted therapeutics and immunotherapy-based treatments for urologic cancers. Her research interest is in bladder cancer and bringing new cancer cell therapies to treat solid malignancies. Dr. Nadal developed the first clinical trial of engineered T-cells targeting human endogenous retrovirus E for kidney cancer. As a native Spanish speaker, she enjoy working with patients who prefer to communicate in the Spanish language and advocates for these patients' inclusion in clinical trials.
